| 1 | those | 72,601 |
| 2 | first-treated | 7 |
| 3 | 2673 | 5 |
| 4 | me3sin3 | 4 |
| 5 | non-satisfied | 4 |
| 6 | preparation-action | 4 |
| 7 | secundiparas | 4 |
| 8 | ~bullet~patients | 4 |
| 9 | 'on-time | 3 |
| 10 | 2825 | 3 |
| 11 | adeno-gh | 3 |
| 12 | hmgri-induced | 3 |
| 13 | hsas | 3 |
| 14 | non-meditators | 3 |
| 15 | oa/ra | 3 |
| 16 | opscca | 3 |
| 17 | pacients | 3 |
| 18 | s-ketoprofen | 3 |
| 19 | sang-a | 3 |
| 20 | tdf/ftc+zdv | 3 |
| 21 | γ-dose | 3 |
| 22 | 'letter | 2 |
| 23 | -insulins | 2 |
| 24 | 1,6-β-d-glucans | 2 |
| 25 | 15,570 | 2 |
| 26 | 16.7°c | 2 |
| 27 | 17,670 | 2 |
| 28 | 1:16,000 | 2 |
| 29 | 2,367 | 2 |
| 30 | 2,521 | 2 |
| 31 | 2012.patients | 2 |
| 32 | 21-year-olds | 2 |
| 33 | 3,5,5-trimethyl-2,3-epoxycyclohexan-1-ones | 2 |
| 34 | 3-aminonaphthalene-2-carbaldehyde | 2 |
| 35 | 3-halochromones | 2 |
| 36 | 31/12/2010 | 2 |
| 37 | 3504 | 2 |
| 38 | 4,474 | 2 |
| 39 | 4766 | 2 |
| 40 | 5,126 | 2 |
| 41 | 5485 | 2 |
| 42 | 7mg/dl | 2 |
| 43 | 8788 | 2 |
| 44 | 9470 | 2 |
| 45 | acid-thermal | 2 |
| 46 | chembl | 2 |
| 47 | co-amendment | 2 |
| 48 | co-regulators | 2 |
| 49 | control-condition | 2 |
| 50 | ct-hdl | 2 |
| 51 | cu-mt2 | 2 |
| 52 | disenchantment | 2 |
| 53 | ebnp | 2 |
| 54 | hla-dq2/8-negative | 2 |
| 55 | instantiations | 2 |
| 56 | nausea.women | 2 |
| 57 | non-duloxetine | 2 |
| 58 | nonclamping | 2 |
| 59 | pj/pg | 2 |
| 60 | rilutek | 2 |
| 61 | self-cic | 2 |
| 62 | slvs | 2 |
| 63 | suspicious/atypical | 2 |
| 64 | ta-group | 2 |
| 65 | testcrosses | 2 |
| 66 | tissue-autoradiography | 2 |
| 67 | trace-elements | 2 |
| 68 | vcl3 | 2 |
| 69 | vrnps | 2 |
| 70 | 'people | 1 |
| 71 | 'successfully | 1 |
| 72 | +/-0.01 | 1 |
| 73 | .930 | 1 |
| 74 | //www.clinicaltrials.gov/nct00672334 | 1 |
| 75 | 0.32ng/ml | 1 |
| 76 | 1,3-indanedione | 1 |
| 77 | 1-benefit | 1 |
| 78 | 1.1mamp | 1 |
| 79 | 1.72nm | 1 |
| 80 | 100,175 | 1 |
| 81 | 100-disease | 1 |
| 82 | 100f | 1 |
| 83 | 104f | 1 |
| 84 | 10μg/dl | 1 |
| 85 | 111-indium-dtpa-octreotide | 1 |
| 86 | 12,604 | 1 |
| 87 | 120milliseconds | 1 |
| 88 | 127,951 | 1 |
| 89 | 136° | 1 |
| 90 | 15,632 | 1 |
| 91 | 17.3±3.5 | 1 |
| 92 | 18-64-years | 1 |
| 93 | 189,000 | 1 |
| 94 | 19,203 | 1 |
| 95 | 19,905 | 1 |
| 96 | 19-nucleotides | 1 |
| 97 | 19-years-old | 1 |
| 98 | 1950-1974 | 1 |
| 99 | 1955-1975 | 1 |
| 100 | 1971-1990 | 1 |
| 101 | 1976cc | 1 |
| 102 | 1b-infection | 1 |
| 103 | 1d-gel | 1 |
| 104 | 2,000-fold | 1 |
| 105 | 2,3-o-isopropylidene-d-threitol | 1 |
| 106 | 2-fracture-patients | 1 |
| 107 | 2/355 | 1 |
| 108 | 2/4+ | 1 |
| 109 | 20,800 | 1 |
| 110 | 220/110 | 1 |
| 111 | 22ca | 1 |
| 112 | 230,220 | 1 |
| 113 | 25v/m | 1 |
| 114 | 3,518 | 1 |
| 115 | 3,959 | 1 |
| 116 | 3-5cm | 1 |
| 117 | 3.0±1.7 | 1 |
| 118 | 3.5mmol/l | 1 |
| 119 | 3/192 | 1 |
| 120 | 30,482 | 1 |
| 121 | 31.4±8.3 | 1 |
| 122 | 312/805 | 1 |
| 123 | 32,688 | 1 |
| 124 | 32000 | 1 |
| 125 | 34000 | 1 |
| 126 | 35,046 | 1 |
| 127 | 358,938 | 1 |
| 128 | 36,115 | 1 |
| 129 | 37/282 | 1 |
| 130 | 398,419 | 1 |
| 131 | 4,654 | 1 |
| 132 | 4,926 | 1 |
| 133 | 4-13-y-olds | 1 |
| 134 | 4-aryl-3-methyl-1,2,3,6-tetrahydropyridine | 1 |
| 135 | 4-hydroxy-2e-nonenal | 1 |
| 136 | 42,024 | 1 |
| 137 | 42e | 1 |
| 138 | 48.8å | 1 |
| 139 | 4803 | 1 |
| 140 | 4μb | 1 |
| 141 | 5.5ml/kg | 1 |
| 142 | 500/100,000 | 1 |
| 143 | 51/47g/m2.7 | 1 |
| 144 | 52.7±6.2 | 1 |
| 145 | 55years | 1 |
| 146 | 58,308 | 1 |
| 147 | 58,940 | 1 |
| 148 | 59,636 | 1 |
| 149 | 6,252 | 1 |
| 150 | 6,472 | 1 |
| 151 | 6/1/2006-12/31/2007 | 1 |
| 152 | 60'000 | 1 |
| 153 | 63,397 | 1 |
| 154 | 65539 | 1 |
| 155 | 6849 | 1 |
| 156 | 7,387 | 1 |
| 157 | 7.5ng | 1 |
| 158 | 7664 | 1 |
| 159 | 7870 | 1 |
| 160 | 8-10-year-olds | 1 |
| 161 | 8.7-9.2 | 1 |
| 162 | 8/353 | 1 |
| 163 | 828/974 | 1 |
| 164 | 85/1,000 | 1 |
| 165 | 88/627 | 1 |
| 166 | 8q22.2-q22.3 | 1 |
| 167 | 9,394 | 1 |
| 168 | 9.50±1.60 | 1 |
| 169 | 9000/μl | 1 |
| 170 | 9087 | 1 |
| 171 | 9400/microl | 1 |
| 172 | :soc1 | 1 |
| 173 | achrab-negative | 1 |
| 174 | acromions | 1 |
| 175 | actomiosin | 1 |
| 176 | adenocarcinoma-in-situ | 1 |
| 177 | adolescents-were | 1 |
| 178 | aggresome-like | 1 |
| 179 | al-au | 1 |
| 180 | alexia | 1 |
| 181 | aml-m1 | 1 |
| 182 | anothergroup | 1 |
| 183 | antidepressant-medicated | 1 |
| 184 | aparasitaemic | 1 |
| 185 | asais | 1 |
| 186 | astronautics | 1 |
| 187 | azd1940were | 1 |
| 188 | b-chains | 1 |
| 189 | bupivakaine | 1 |
| 190 | butanol/hcl | 1 |
| 191 | c-subunits | 1 |
| 192 | cancer.familiarity | 1 |
| 193 | care-managers | 1 |
| 194 | cauterise | 1 |
| 195 | caution.we | 1 |
| 196 | cd24/esa | 1 |
| 197 | cea-particularly | 1 |
| 198 | cellblocks | 1 |
| 199 | chemotherapy/auto-hsct | 1 |
| 200 | children/mothers | 1 |
| 201 | cin-ii-iii | 1 |
| 202 | ckd2-4 | 1 |
| 203 | clopiogrel | 1 |
| 204 | cluster-derived | 1 |
| 205 | coloreds | 1 |
| 206 | conference-debates | 1 |
| 207 | controlwe | 1 |
| 208 | cserkeszölö | 1 |
| 209 | cy-treated | 1 |
| 210 | da/ade | 1 |
| 211 | daa-treated | 1 |
| 212 | dependence- | 1 |
| 213 | dexamethsone | 1 |
| 214 | dimethyhydantoins | 1 |
| 215 | disc/dawba | 1 |
| 216 | dna-pcr-labeling-coupled | 1 |
| 217 | doctor-mask | 1 |
| 218 | dp/centralization | 1 |
| 219 | dth-negative | 1 |
| 220 | dysgravidia | 1 |
| 221 | early-enrolling | 1 |
| 222 | eltreports | 1 |
| 223 | emetropes | 1 |
| 224 | englerophytum | 1 |
| 225 | enhanced-usual-care | 1 |
| 226 | eufolatemic | 1 |
| 227 | ev68-negative | 1 |
| 228 | evangelists | 1 |
| 229 | fenofibrate-assigned | 1 |
| 230 | fi/month | 1 |
| 231 | foodware | 1 |
| 232 | fragment-treated | 1 |
| 233 | friends/caregivers | 1 |
| 234 | g1a-infected | 1 |
| 235 | gasparo | 1 |
| 236 | gate-keepers | 1 |
| 237 | gepc/lacs | 1 |
| 238 | girls-was | 1 |
| 239 | gl-treated | 1 |
| 240 | glycerol-receiving | 1 |
| 241 | go-onthan | 1 |
| 242 | gravida-4 | 1 |
| 243 | hemihypotrophy | 1 |
| 244 | herdmates | 1 |
| 245 | higher-mortality | 1 |
| 246 | hkd | 1 |
| 247 | hodeida | 1 |
| 248 | hydro-flask | 1 |
| 249 | hydrocodone-experienced | 1 |
| 250 | hypercholesterolema | 1 |
| 251 | hypermeteorism | 1 |
| 252 | i-pts | 1 |
| 253 | ii-iie | 1 |
| 254 | ims-assigned | 1 |
| 255 | initial/mr+patients | 1 |
| 256 | internists-respondents | 1 |
| 257 | interventions.women | 1 |
| 258 | ipf-patients | 1 |
| 259 | japanese-are | 1 |
| 260 | keayanine | 1 |
| 261 | labour.we | 1 |
| 262 | laidlaw | 1 |
| 263 | lalonde | 1 |
| 264 | lansoprazole-treated | 1 |
| 265 | ldvd | 1 |
| 266 | lma-group | 1 |
| 267 | lng-iuss | 1 |
| 268 | lys409 | 1 |
| 269 | macrolides/imidazoles/amoxicillin | 1 |
| 270 | managers/stakeholders | 1 |
| 271 | materials/notes | 1 |
| 272 | mdd-only | 1 |
| 273 | menanap | 1 |
| 274 | metronidzole | 1 |
| 275 | mid-surface | 1 |
| 276 | multivariate-but | 1 |
| 277 | n=9563 | 1 |
| 278 | no-ms | 1 |
| 279 | no-ovfi | 1 |
| 280 | nodal-negative | 1 |
| 281 | non-alignment | 1 |
| 282 | non-glycopeptides | 1 |
| 283 | non-iasd | 1 |
| 284 | non-lada | 1 |
| 285 | non-lwbs | 1 |
| 286 | non-peas | 1 |
| 287 | non-plated | 1 |
| 288 | non-pour | 1 |
| 289 | nonectopic | 1 |
| 290 | nonincident | 1 |
| 291 | nonprobationers/parolees | 1 |
| 292 | nonrejecters | 1 |
| 293 | o-allylation | 1 |
| 294 | o:3a | 1 |
| 295 | orthotropia | 1 |
| 296 | palmitate-but | 1 |
| 297 | parkinsonism-17 | 1 |
| 298 | pedestals | 1 |
| 299 | pegaptanib.participants | 1 |
| 300 | placebo+ca+d | 1 |
| 301 | placebo.patients | 1 |
| 302 | population-patients | 1 |
| 303 | pregnancy.we | 1 |
| 304 | pressure-ulcers | 1 |
| 305 | pro-embryos | 1 |
| 306 | pt3-tumors | 1 |
| 307 | quetelet-index | 1 |
| 308 | radio-density | 1 |
| 309 | rah.women | 1 |
| 310 | rapid-sequence-induction | 1 |
| 311 | ratg-treated | 1 |
| 312 | rbcgs | 1 |
| 313 | rhymed | 1 |
| 314 | ribavirins | 1 |
| 315 | right-breast | 1 |
| 316 | rsb1 | 1 |
| 317 | rts-pdt | 1 |
| 318 | salmeterol/ics | 1 |
| 319 | scleropathy | 1 |
| 320 | self-gating | 1 |
| 321 | sentaurus | 1 |
| 322 | ser-responders | 1 |
| 323 | sf-il-6 | 1 |
| 324 | shushrutha | 1 |
| 325 | spoon-fed | 1 |
| 326 | stadiometers | 1 |
| 327 | strain-when | 1 |
| 328 | structur2 | 1 |
| 329 | sunitinb | 1 |
| 330 | t10-12 | 1 |
| 331 | tangibly | 1 |
| 332 | taurodintism | 1 |
| 333 | the-patients | 1 |
| 334 | third-graders | 1 |
| 335 | thoracotoiny | 1 |
| 336 | thsoe | 1 |
| 337 | tp53inp1 | 1 |
| 338 | tra- | 1 |
| 339 | trans-cyclooctenol | 1 |
| 340 | treatment-non-resistant | 1 |
| 341 | treatment-patients | 1 |
| 342 | trichostrongyles | 1 |
| 343 | trisome-21 | 1 |
| 344 | ugt1a10 | 1 |
| 345 | uriticaria | 1 |
| 346 | us-mst | 1 |
| 347 | uv-b+uv-a | 1 |
| 348 | uv-ot | 1 |
| 349 | v=intervention | 1 |
| 350 | vocoders | 1 |
| 351 | wait-listing/transplantation | 1 |
| 352 | withwomen | 1 |
| 353 | wlds | 1 |
| 354 | women/couples | 1 |
| 355 | yg1041 | 1 |
| 356 | znojmo | 1 |
| 357 | £22,200 | 1 |
| 358 | £308 | 1 |
| 359 | β-1,3-galactopentaose | 1 |
| 360 | €129 | 1 |
| 361 | ≥75-year-olds | 1 |
| 1 | 'letter | 2 |
| 2 | 'on-time | 3 |
| 3 | 'people | 1 |
| 4 | 'successfully | 1 |
| 5 | +/-0.01 | 1 |
| 6 | -insulins | 2 |
| 7 | .930 | 1 |
| 8 | //www.clinicaltrials.gov/nct00672334 | 1 |
| 9 | 0.32ng/ml | 1 |
| 10 | 1,3-indanedione | 1 |
| 11 | 1,6-β-d-glucans | 2 |
| 12 | 1-benefit | 1 |
| 13 | 1.1mamp | 1 |
| 14 | 1.72nm | 1 |
| 15 | 100,175 | 1 |
| 16 | 100-disease | 1 |
| 17 | 100f | 1 |
| 18 | 104f | 1 |
| 19 | 10μg/dl | 1 |
| 20 | 111-indium-dtpa-octreotide | 1 |
| 21 | 12,604 | 1 |
| 22 | 120milliseconds | 1 |
| 23 | 127,951 | 1 |
| 24 | 136° | 1 |
| 25 | 15,570 | 2 |
| 26 | 15,632 | 1 |
| 27 | 16.7°c | 2 |
| 28 | 17,670 | 2 |
| 29 | 17.3±3.5 | 1 |
| 30 | 18-64-years | 1 |
| 31 | 189,000 | 1 |
| 32 | 19,203 | 1 |
| 33 | 19,905 | 1 |
| 34 | 19-nucleotides | 1 |
| 35 | 19-years-old | 1 |
| 36 | 1950-1974 | 1 |
| 37 | 1955-1975 | 1 |
| 38 | 1971-1990 | 1 |
| 39 | 1976cc | 1 |
| 40 | 1:16,000 | 2 |
| 41 | 1b-infection | 1 |
| 42 | 1d-gel | 1 |
| 43 | 2,000-fold | 1 |
| 44 | 2,3-o-isopropylidene-d-threitol | 1 |
| 45 | 2,367 | 2 |
| 46 | 2,521 | 2 |
| 47 | 2-fracture-patients | 1 |
| 48 | 2/355 | 1 |
| 49 | 2/4+ | 1 |
| 50 | 20,800 | 1 |
| 51 | 2012.patients | 2 |
| 52 | 21-year-olds | 2 |
| 53 | 220/110 | 1 |
| 54 | 22ca | 1 |
| 55 | 230,220 | 1 |
| 56 | 25v/m | 1 |
| 57 | 2673 | 5 |
| 58 | 2825 | 3 |
| 59 | 3,5,5-trimethyl-2,3-epoxycyclohexan-1-ones | 2 |
| 60 | 3,518 | 1 |
| 61 | 3,959 | 1 |
| 62 | 3-5cm | 1 |
| 63 | 3-aminonaphthalene-2-carbaldehyde | 2 |
| 64 | 3-halochromones | 2 |
| 65 | 3.0±1.7 | 1 |
| 66 | 3.5mmol/l | 1 |
| 67 | 3/192 | 1 |
| 68 | 30,482 | 1 |
| 69 | 31.4±8.3 | 1 |
| 70 | 31/12/2010 | 2 |
| 71 | 312/805 | 1 |
| 72 | 32,688 | 1 |
| 73 | 32000 | 1 |
| 74 | 34000 | 1 |
| 75 | 35,046 | 1 |
| 76 | 3504 | 2 |
| 77 | 358,938 | 1 |
| 78 | 36,115 | 1 |
| 79 | 37/282 | 1 |
| 80 | 398,419 | 1 |
| 81 | 4,474 | 2 |
| 82 | 4,654 | 1 |
| 83 | 4,926 | 1 |
| 84 | 4-13-y-olds | 1 |
| 85 | 4-aryl-3-methyl-1,2,3,6-tetrahydropyridine | 1 |
| 86 | 4-hydroxy-2e-nonenal | 1 |
| 87 | 42,024 | 1 |
| 88 | 42e | 1 |
| 89 | 4766 | 2 |
| 90 | 48.8å | 1 |
| 91 | 4803 | 1 |
| 92 | 4μb | 1 |
| 93 | 5,126 | 2 |
| 94 | 5.5ml/kg | 1 |
| 95 | 500/100,000 | 1 |
| 96 | 51/47g/m2.7 | 1 |
| 97 | 52.7±6.2 | 1 |
| 98 | 5485 | 2 |
| 99 | 55years | 1 |
| 100 | 58,308 | 1 |
| 101 | 58,940 | 1 |
| 102 | 59,636 | 1 |
| 103 | 6,252 | 1 |
| 104 | 6,472 | 1 |
| 105 | 6/1/2006-12/31/2007 | 1 |
| 106 | 60'000 | 1 |
| 107 | 63,397 | 1 |
| 108 | 65539 | 1 |
| 109 | 6849 | 1 |
| 110 | 7,387 | 1 |
| 111 | 7.5ng | 1 |
| 112 | 7664 | 1 |
| 113 | 7870 | 1 |
| 114 | 7mg/dl | 2 |
| 115 | 8-10-year-olds | 1 |
| 116 | 8.7-9.2 | 1 |
| 117 | 8/353 | 1 |
| 118 | 828/974 | 1 |
| 119 | 85/1,000 | 1 |
| 120 | 8788 | 2 |
| 121 | 88/627 | 1 |
| 122 | 8q22.2-q22.3 | 1 |
| 123 | 9,394 | 1 |
| 124 | 9.50±1.60 | 1 |
| 125 | 9000/μl | 1 |
| 126 | 9087 | 1 |
| 127 | 9400/microl | 1 |
| 128 | 9470 | 2 |
| 129 | :soc1 | 1 |
| 130 | achrab-negative | 1 |
| 131 | acid-thermal | 2 |
| 132 | acromions | 1 |
| 133 | actomiosin | 1 |
| 134 | adeno-gh | 3 |
| 135 | adenocarcinoma-in-situ | 1 |
| 136 | adolescents-were | 1 |
| 137 | aggresome-like | 1 |
| 138 | al-au | 1 |
| 139 | alexia | 1 |
| 140 | aml-m1 | 1 |
| 141 | anothergroup | 1 |
| 142 | antidepressant-medicated | 1 |
| 143 | aparasitaemic | 1 |
| 144 | asais | 1 |
| 145 | astronautics | 1 |
| 146 | azd1940were | 1 |
| 147 | b-chains | 1 |
| 148 | bupivakaine | 1 |
| 149 | butanol/hcl | 1 |
| 150 | c-subunits | 1 |
| 151 | cancer.familiarity | 1 |
| 152 | care-managers | 1 |
| 153 | cauterise | 1 |
| 154 | caution.we | 1 |
| 155 | cd24/esa | 1 |
| 156 | cea-particularly | 1 |
| 157 | cellblocks | 1 |
| 158 | chembl | 2 |
| 159 | chemotherapy/auto-hsct | 1 |
| 160 | children/mothers | 1 |
| 161 | cin-ii-iii | 1 |
| 162 | ckd2-4 | 1 |
| 163 | clopiogrel | 1 |
| 164 | cluster-derived | 1 |
| 165 | co-amendment | 2 |
| 166 | co-regulators | 2 |
| 167 | coloreds | 1 |
| 168 | conference-debates | 1 |
| 169 | control-condition | 2 |
| 170 | controlwe | 1 |
| 171 | cserkeszölö | 1 |
| 172 | ct-hdl | 2 |
| 173 | cu-mt2 | 2 |
| 174 | cy-treated | 1 |
| 175 | da/ade | 1 |
| 176 | daa-treated | 1 |
| 177 | dependence- | 1 |
| 178 | dexamethsone | 1 |
| 179 | dimethyhydantoins | 1 |
| 180 | disc/dawba | 1 |
| 181 | disenchantment | 2 |
| 182 | dna-pcr-labeling-coupled | 1 |
| 183 | doctor-mask | 1 |
| 184 | dp/centralization | 1 |
| 185 | dth-negative | 1 |
| 186 | dysgravidia | 1 |
| 187 | early-enrolling | 1 |
| 188 | ebnp | 2 |
| 189 | eltreports | 1 |
| 190 | emetropes | 1 |
| 191 | englerophytum | 1 |
| 192 | enhanced-usual-care | 1 |
| 193 | eufolatemic | 1 |
| 194 | ev68-negative | 1 |
| 195 | evangelists | 1 |
| 196 | fenofibrate-assigned | 1 |
| 197 | fi/month | 1 |
| 198 | first-treated | 7 |
| 199 | foodware | 1 |
| 200 | fragment-treated | 1 |
| 201 | friends/caregivers | 1 |
| 202 | g1a-infected | 1 |
| 203 | gasparo | 1 |
| 204 | gate-keepers | 1 |
| 205 | gepc/lacs | 1 |
| 206 | girls-was | 1 |
| 207 | gl-treated | 1 |
| 208 | glycerol-receiving | 1 |
| 209 | go-onthan | 1 |
| 210 | gravida-4 | 1 |
| 211 | hemihypotrophy | 1 |
| 212 | herdmates | 1 |
| 213 | higher-mortality | 1 |
| 214 | hkd | 1 |
| 215 | hla-dq2/8-negative | 2 |
| 216 | hmgri-induced | 3 |
| 217 | hodeida | 1 |
| 218 | hsas | 3 |
| 219 | hydro-flask | 1 |
| 220 | hydrocodone-experienced | 1 |
| 221 | hypercholesterolema | 1 |
| 222 | hypermeteorism | 1 |
| 223 | i-pts | 1 |
| 224 | ii-iie | 1 |
| 225 | ims-assigned | 1 |
| 226 | initial/mr+patients | 1 |
| 227 | instantiations | 2 |
| 228 | internists-respondents | 1 |
| 229 | interventions.women | 1 |
| 230 | ipf-patients | 1 |
| 231 | japanese-are | 1 |
| 232 | keayanine | 1 |
| 233 | labour.we | 1 |
| 234 | laidlaw | 1 |
| 235 | lalonde | 1 |
| 236 | lansoprazole-treated | 1 |
| 237 | ldvd | 1 |
| 238 | lma-group | 1 |
| 239 | lng-iuss | 1 |
| 240 | lys409 | 1 |
| 241 | macrolides/imidazoles/amoxicillin | 1 |
| 242 | managers/stakeholders | 1 |
| 243 | materials/notes | 1 |
| 244 | mdd-only | 1 |
| 245 | me3sin3 | 4 |
| 246 | menanap | 1 |
| 247 | metronidzole | 1 |
| 248 | mid-surface | 1 |
| 249 | multivariate-but | 1 |
| 250 | n=9563 | 1 |
| 251 | nausea.women | 2 |
| 252 | no-ms | 1 |
| 253 | no-ovfi | 1 |
| 254 | nodal-negative | 1 |
| 255 | non-alignment | 1 |
| 256 | non-duloxetine | 2 |
| 257 | non-glycopeptides | 1 |
| 258 | non-iasd | 1 |
| 259 | non-lada | 1 |
| 260 | non-lwbs | 1 |
| 261 | non-meditators | 3 |
| 262 | non-peas | 1 |
| 263 | non-plated | 1 |
| 264 | non-pour | 1 |
| 265 | non-satisfied | 4 |
| 266 | nonclamping | 2 |
| 267 | nonectopic | 1 |
| 268 | nonincident | 1 |
| 269 | nonprobationers/parolees | 1 |
| 270 | nonrejecters | 1 |
| 271 | o-allylation | 1 |
| 272 | o:3a | 1 |
| 273 | oa/ra | 3 |
| 274 | opscca | 3 |
| 275 | orthotropia | 1 |
| 276 | pacients | 3 |
| 277 | palmitate-but | 1 |
| 278 | parkinsonism-17 | 1 |
| 279 | pedestals | 1 |
| 280 | pegaptanib.participants | 1 |
| 281 | pj/pg | 2 |
| 282 | placebo+ca+d | 1 |
| 283 | placebo.patients | 1 |
| 284 | population-patients | 1 |
| 285 | pregnancy.we | 1 |
| 286 | preparation-action | 4 |
| 287 | pressure-ulcers | 1 |
| 288 | pro-embryos | 1 |
| 289 | pt3-tumors | 1 |
| 290 | quetelet-index | 1 |
| 291 | radio-density | 1 |
| 292 | rah.women | 1 |
| 293 | rapid-sequence-induction | 1 |
| 294 | ratg-treated | 1 |
| 295 | rbcgs | 1 |
| 296 | rhymed | 1 |
| 297 | ribavirins | 1 |
| 298 | right-breast | 1 |
| 299 | rilutek | 2 |
| 300 | rsb1 | 1 |
| 301 | rts-pdt | 1 |
| 302 | s-ketoprofen | 3 |
| 303 | salmeterol/ics | 1 |
| 304 | sang-a | 3 |
| 305 | scleropathy | 1 |
| 306 | secundiparas | 4 |
| 307 | self-cic | 2 |
| 308 | self-gating | 1 |
| 309 | sentaurus | 1 |
| 310 | ser-responders | 1 |
| 311 | sf-il-6 | 1 |
| 312 | shushrutha | 1 |
| 313 | slvs | 2 |
| 314 | spoon-fed | 1 |
| 315 | stadiometers | 1 |
| 316 | strain-when | 1 |
| 317 | structur2 | 1 |
| 318 | sunitinb | 1 |
| 319 | suspicious/atypical | 2 |
| 320 | t10-12 | 1 |
| 321 | ta-group | 2 |
| 322 | tangibly | 1 |
| 323 | taurodintism | 1 |
| 324 | tdf/ftc+zdv | 3 |
| 325 | testcrosses | 2 |
| 326 | the-patients | 1 |
| 327 | third-graders | 1 |
| 328 | thoracotoiny | 1 |
| 329 | those | 72,601 |
| 330 | thsoe | 1 |
| 331 | tissue-autoradiography | 2 |
| 332 | tp53inp1 | 1 |
| 333 | tra- | 1 |
| 334 | trace-elements | 2 |
| 335 | trans-cyclooctenol | 1 |
| 336 | treatment-non-resistant | 1 |
| 337 | treatment-patients | 1 |
| 338 | trichostrongyles | 1 |
| 339 | trisome-21 | 1 |
| 340 | ugt1a10 | 1 |
| 341 | uriticaria | 1 |
| 342 | us-mst | 1 |
| 343 | uv-b+uv-a | 1 |
| 344 | uv-ot | 1 |
| 345 | v=intervention | 1 |
| 346 | vcl3 | 2 |
| 347 | vocoders | 1 |
| 348 | vrnps | 2 |
| 349 | wait-listing/transplantation | 1 |
| 350 | withwomen | 1 |
| 351 | wlds | 1 |
| 352 | women/couples | 1 |
| 353 | yg1041 | 1 |
| 354 | znojmo | 1 |
| 355 | ~bullet~patients | 4 |
| 356 | £22,200 | 1 |
| 357 | £308 | 1 |
| 358 | β-1,3-galactopentaose | 1 |
| 359 | γ-dose | 3 |
| 360 | €129 | 1 |
| 361 | ≥75-year-olds | 1 |
| 1 | 2/4+ | 1 |
| 2 | tra- | 1 |
| 3 | dependence- | 1 |
| 4 | 60'000 | 1 |
| 5 | 500/100,000 | 1 |
| 6 | 85/1,000 | 1 |
| 7 | 1:16,000 | 2 |
| 8 | 189,000 | 1 |
| 9 | 32000 | 1 |
| 10 | 34000 | 1 |
| 11 | £22,200 | 1 |
| 12 | 20,800 | 1 |
| 13 | 31/12/2010 | 2 |
| 14 | 220/110 | 1 |
| 15 | ugt1a10 | 1 |
| 16 | 230,220 | 1 |
| 17 | .930 | 1 |
| 18 | 58,940 | 1 |
| 19 | 9.50±1.60 | 1 |
| 20 | 9470 | 2 |
| 21 | 15,570 | 2 |
| 22 | 17,670 | 2 |
| 23 | 7870 | 1 |
| 24 | 1971-1990 | 1 |
| 25 | +/-0.01 | 1 |
| 26 | trisome-21 | 1 |
| 27 | 2,521 | 2 |
| 28 | yg1041 | 1 |
| 29 | 127,951 | 1 |
| 30 | rsb1 | 1 |
| 31 | :soc1 | 1 |
| 32 | aml-m1 | 1 |
| 33 | tp53inp1 | 1 |
| 34 | 52.7±6.2 | 1 |
| 35 | 8.7-9.2 | 1 |
| 36 | t10-12 | 1 |
| 37 | 15,632 | 1 |
| 38 | 6,252 | 1 |
| 39 | 6,472 | 1 |
| 40 | 37/282 | 1 |
| 41 | 30,482 | 1 |
| 42 | 3/192 | 1 |
| 43 | structur2 | 1 |
| 44 | cu-mt2 | 2 |
| 45 | 8q22.2-q22.3 | 1 |
| 46 | 31.4±8.3 | 1 |
| 47 | 19,203 | 1 |
| 48 | 4803 | 1 |
| 49 | 8/353 | 1 |
| 50 | n=9563 | 1 |
| 51 | 2673 | 5 |
| 52 | vcl3 | 2 |
| 53 | me3sin3 | 4 |
| 54 | ckd2-4 | 1 |
| 55 | gravida-4 | 1 |
| 56 | 3504 | 2 |
| 57 | 12,604 | 1 |
| 58 | 42,024 | 1 |
| 59 | //www.clinicaltrials.gov/nct00672334 | 1 |
| 60 | 4,654 | 1 |
| 61 | 7664 | 1 |
| 62 | 4,474 | 2 |
| 63 | 828/974 | 1 |
| 64 | 1950-1974 | 1 |
| 65 | 9,394 | 1 |
| 66 | 17.3±3.5 | 1 |
| 67 | 312/805 | 1 |
| 68 | 19,905 | 1 |
| 69 | 36,115 | 1 |
| 70 | 2825 | 3 |
| 71 | 2/355 | 1 |
| 72 | 100,175 | 1 |
| 73 | 1955-1975 | 1 |
| 74 | 5485 | 2 |
| 75 | sf-il-6 | 1 |
| 76 | 5,126 | 2 |
| 77 | 4,926 | 1 |
| 78 | 59,636 | 1 |
| 79 | 35,046 | 1 |
| 80 | 4766 | 2 |
| 81 | 3.0±1.7 | 1 |
| 82 | 51/47g/m2.7 | 1 |
| 83 | 6/1/2006-12/31/2007 | 1 |
| 84 | parkinsonism-17 | 1 |
| 85 | 88/627 | 1 |
| 86 | 2,367 | 2 |
| 87 | 9087 | 1 |
| 88 | 7,387 | 1 |
| 89 | 63,397 | 1 |
| 90 | 58,308 | 1 |
| 91 | £308 | 1 |
| 92 | 3,518 | 1 |
| 93 | 358,938 | 1 |
| 94 | 32,688 | 1 |
| 95 | 8788 | 2 |
| 96 | lys409 | 1 |
| 97 | 398,419 | 1 |
| 98 | €129 | 1 |
| 99 | 65539 | 1 |
| 100 | 6849 | 1 |
| 101 | 3,959 | 1 |
| 102 | sang-a | 3 |
| 103 | uv-b+uv-a | 1 |
| 104 | o:3a | 1 |
| 105 | disc/dawba | 1 |
| 106 | 22ca | 1 |
| 107 | opscca | 3 |
| 108 | non-lada | 1 |
| 109 | hodeida | 1 |
| 110 | shushrutha | 1 |
| 111 | dysgravidia | 1 |
| 112 | orthotropia | 1 |
| 113 | uriticaria | 1 |
| 114 | alexia | 1 |
| 115 | hypercholesterolema | 1 |
| 116 | oa/ra | 3 |
| 117 | cd24/esa | 1 |
| 118 | sunitinb | 1 |
| 119 | 4μb | 1 |
| 120 | 1976cc | 1 |
| 121 | self-cic | 2 |
| 122 | aparasitaemic | 1 |
| 123 | eufolatemic | 1 |
| 124 | nonectopic | 1 |
| 125 | 16.7°c | 2 |
| 126 | placebo+ca+d | 1 |
| 127 | hydrocodone-experienced | 1 |
| 128 | hmgri-induced | 3 |
| 129 | spoon-fed | 1 |
| 130 | non-satisfied | 4 |
| 131 | dna-pcr-labeling-coupled | 1 |
| 132 | rhymed | 1 |
| 133 | fenofibrate-assigned | 1 |
| 134 | ims-assigned | 1 |
| 135 | antidepressant-medicated | 1 |
| 136 | daa-treated | 1 |
| 137 | lansoprazole-treated | 1 |
| 138 | ratg-treated | 1 |
| 139 | gl-treated | 1 |
| 140 | fragment-treated | 1 |
| 141 | first-treated | 7 |
| 142 | cy-treated | 1 |
| 143 | non-plated | 1 |
| 144 | g1a-infected | 1 |
| 145 | cluster-derived | 1 |
| 146 | hkd | 1 |
| 147 | 19-years-old | 1 |
| 148 | 2,000-fold | 1 |
| 149 | non-iasd | 1 |
| 150 | ldvd | 1 |
| 151 | 42e | 1 |
| 152 | mid-surface | 1 |
| 153 | da/ade | 1 |
| 154 | 111-indium-dtpa-octreotide | 1 |
| 155 | lalonde | 1 |
| 156 | 3-aminonaphthalene-2-carbaldehyde | 2 |
| 157 | ii-iie | 1 |
| 158 | aggresome-like | 1 |
| 159 | metronidzole | 1 |
| 160 | 'people | 1 |
| 161 | 'on-time | 3 |
| 162 | bupivakaine | 1 |
| 163 | 4-aryl-3-methyl-1,2,3,6-tetrahydropyridine | 1 |
| 164 | keayanine | 1 |
| 165 | non-duloxetine | 2 |
| 166 | 1,3-indanedione | 1 |
| 167 | dexamethsone | 1 |
| 168 | thsoe | 1 |
| 169 | japanese-are | 1 |
| 170 | enhanced-usual-care | 1 |
| 171 | foodware | 1 |
| 172 | adolescents-were | 1 |
| 173 | azd1940were | 1 |
| 174 | 100-disease | 1 |
| 175 | cauterise | 1 |
| 176 | β-1,3-galactopentaose | 1 |
| 177 | γ-dose | 3 |
| 178 | those | 72,601 |
| 179 | hla-dq2/8-negative | 2 |
| 180 | ev68-negative | 1 |
| 181 | achrab-negative | 1 |
| 182 | dth-negative | 1 |
| 183 | nodal-negative | 1 |
| 184 | caution.we | 1 |
| 185 | labour.we | 1 |
| 186 | pregnancy.we | 1 |
| 187 | controlwe | 1 |
| 188 | 100f | 1 |
| 189 | 104f | 1 |
| 190 | 5.5ml/kg | 1 |
| 191 | 7.5ng | 1 |
| 192 | early-enrolling | 1 |
| 193 | nonclamping | 2 |
| 194 | self-gating | 1 |
| 195 | glycerol-receiving | 1 |
| 196 | pj/pg | 2 |
| 197 | adeno-gh | 3 |
| 198 | fi/month | 1 |
| 199 | no-ovfi | 1 |
| 200 | cin-ii-iii | 1 |
| 201 | rilutek | 2 |
| 202 | hydro-flask | 1 |
| 203 | doctor-mask | 1 |
| 204 | 3.5mmol/l | 1 |
| 205 | suspicious/atypical | 2 |
| 206 | acid-thermal | 2 |
| 207 | 4-hydroxy-2e-nonenal | 1 |
| 208 | chembl | 2 |
| 209 | butanol/hcl | 1 |
| 210 | 7mg/dl | 2 |
| 211 | 10μg/dl | 1 |
| 212 | ct-hdl | 2 |
| 213 | 1d-gel | 1 |
| 214 | clopiogrel | 1 |
| 215 | 0.32ng/ml | 1 |
| 216 | trans-cyclooctenol | 1 |
| 217 | 9400/microl | 1 |
| 218 | 2,3-o-isopropylidene-d-threitol | 1 |
| 219 | 9000/μl | 1 |
| 220 | 25v/m | 1 |
| 221 | 3-5cm | 1 |
| 222 | 1.72nm | 1 |
| 223 | hypermeteorism | 1 |
| 224 | taurodintism | 1 |
| 225 | englerophytum | 1 |
| 226 | go-onthan | 1 |
| 227 | s-ketoprofen | 3 |
| 228 | strain-when | 1 |
| 229 | nausea.women | 2 |
| 230 | rah.women | 1 |
| 231 | interventions.women | 1 |
| 232 | withwomen | 1 |
| 233 | macrolides/imidazoles/amoxicillin | 1 |
| 234 | actomiosin | 1 |
| 235 | o-allylation | 1 |
| 236 | wait-listing/transplantation | 1 |
| 237 | dp/centralization | 1 |
| 238 | preparation-action | 4 |
| 239 | 1b-infection | 1 |
| 240 | rapid-sequence-induction | 1 |
| 241 | control-condition | 2 |
| 242 | v=intervention | 1 |
| 243 | znojmo | 1 |
| 244 | gasparo | 1 |
| 245 | menanap | 1 |
| 246 | 1.1mamp | 1 |
| 247 | ebnp | 2 |
| 248 | lma-group | 1 |
| 249 | ta-group | 2 |
| 250 | anothergroup | 1 |
| 251 | 'letter | 2 |
| 252 | non-pour | 1 |
| 253 | non-peas | 1 |
| 254 | secundiparas | 4 |
| 255 | hsas | 3 |
| 256 | girls-was | 1 |
| 257 | non-lwbs | 1 |
| 258 | gepc/lacs | 1 |
| 259 | salmeterol/ics | 1 |
| 260 | astronautics | 1 |
| 261 | coloreds | 1 |
| 262 | 8-10-year-olds | 1 |
| 263 | 21-year-olds | 2 |
| 264 | ≥75-year-olds | 1 |
| 265 | 4-13-y-olds | 1 |
| 266 | wlds | 1 |
| 267 | 120milliseconds | 1 |
| 268 | 19-nucleotides | 1 |
| 269 | non-glycopeptides | 1 |
| 270 | nonprobationers/parolees | 1 |
| 271 | women/couples | 1 |
| 272 | trichostrongyles | 1 |
| 273 | 3,5,5-trimethyl-2,3-epoxycyclohexan-1-ones | 2 |
| 274 | 3-halochromones | 2 |
| 275 | emetropes | 1 |
| 276 | testcrosses | 2 |
| 277 | conference-debates | 1 |
| 278 | herdmates | 1 |
| 279 | materials/notes | 1 |
| 280 | rbcgs | 1 |
| 281 | asais | 1 |
| 282 | cellblocks | 1 |
| 283 | pedestals | 1 |
| 284 | no-ms | 1 |
| 285 | 1,6-β-d-glucans | 2 |
| 286 | b-chains | 1 |
| 287 | -insulins | 2 |
| 288 | dimethyhydantoins | 1 |
| 289 | ribavirins | 1 |
| 290 | acromions | 1 |
| 291 | instantiations | 2 |
| 292 | pro-embryos | 1 |
| 293 | vrnps | 2 |
| 294 | 18-64-years | 1 |
| 295 | 55years | 1 |
| 296 | pressure-ulcers | 1 |
| 297 | third-graders | 1 |
| 298 | managers/stakeholders | 1 |
| 299 | ser-responders | 1 |
| 300 | vocoders | 1 |
| 301 | care-managers | 1 |
| 302 | children/mothers | 1 |
| 303 | gate-keepers | 1 |
| 304 | nonrejecters | 1 |
| 305 | stadiometers | 1 |
| 306 | friends/caregivers | 1 |
| 307 | pt3-tumors | 1 |
| 308 | co-regulators | 2 |
| 309 | non-meditators | 3 |
| 310 | lng-iuss | 1 |
| 311 | c-subunits | 1 |
| 312 | pegaptanib.participants | 1 |
| 313 | internists-respondents | 1 |
| 314 | pacients | 3 |
| 315 | initial/mr+patients | 1 |
| 316 | the-patients | 1 |
| 317 | 2-fracture-patients | 1 |
| 318 | ipf-patients | 1 |
| 319 | population-patients | 1 |
| 320 | treatment-patients | 1 |
| 321 | 2012.patients | 2 |
| 322 | placebo.patients | 1 |
| 323 | ~bullet~patients | 4 |
| 324 | trace-elements | 2 |
| 325 | i-pts | 1 |
| 326 | eltreports | 1 |
| 327 | evangelists | 1 |
| 328 | sentaurus | 1 |
| 329 | slvs | 2 |
| 330 | chemotherapy/auto-hsct | 1 |
| 331 | rts-pdt | 1 |
| 332 | 1-benefit | 1 |
| 333 | treatment-non-resistant | 1 |
| 334 | nonincident | 1 |
| 335 | co-amendment | 2 |
| 336 | non-alignment | 1 |
| 337 | disenchantment | 2 |
| 338 | uv-ot | 1 |
| 339 | right-breast | 1 |
| 340 | us-mst | 1 |
| 341 | multivariate-but | 1 |
| 342 | palmitate-but | 1 |
| 343 | al-au | 1 |
| 344 | adenocarcinoma-in-situ | 1 |
| 345 | tdf/ftc+zdv | 3 |
| 346 | laidlaw | 1 |
| 347 | quetelet-index | 1 |
| 348 | tissue-autoradiography | 2 |
| 349 | hemihypotrophy | 1 |
| 350 | scleropathy | 1 |
| 351 | tangibly | 1 |
| 352 | 'successfully | 1 |
| 353 | mdd-only | 1 |
| 354 | cea-particularly | 1 |
| 355 | thoracotoiny | 1 |
| 356 | higher-mortality | 1 |
| 357 | cancer.familiarity | 1 |
| 358 | radio-density | 1 |
| 359 | 48.8å | 1 |
| 360 | 136° | 1 |
| 361 | cserkeszölö | 1 |